Chemoinformaics analysis of (5E,7E)-dodeca-5,7-diene
| Molecular Weight | 166.308 | nRot | 7 |
| Heavy Atom Molecular Weight | 144.132 | nRig | 2 |
| Exact Molecular Weight | 166.172 | nRing | 0 |
| Solubility: LogS | -3.665 | nHRing | 0 |
| Solubility: LogP | 4.287 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 34 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 12 | No. of Aromatic Carbocycles | 0 |
| nHetero | 0 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 22 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 12 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 0 | No. of Arom Bond | 0 |
| nHA | 0 | APOL | 34.7094 |
| nHD | 0 | BPOL | 22.0706 |
| QED | 0.386 |
| Synth | 2.457 |
| Natural Product Likeliness | 1.306 |
| NR-PPAR-gamma | 0.003 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.001 |
| Pgp-sub | 0.001 |
| HIA | 0.004 |
| CACO-2 | -4.449 |
| MDCK | 0.0000255 |
| BBB | 0.742 |
| PPB | 0.95322 |
| VDSS | 1.094 |
| FU | 0.0386287 |
| CYP1A2-inh | 0.952 |
| CYP1A2-sub | 0.858 |
| CYP2c19-inh | 0.778 |
| CYP2c19-sub | 0.866 |
| CYP2c9-inh | 0.492 |
| CYP2c9-sub | 0.983 |
| CYP2d6-inh | 0.84 |
| CYP2d6-sub | 0.927 |
| CYP3a4-inh | 0.582 |
| CYP3a4-sub | 0.172 |
| CL | 3.846 |
| T12 | 0.268 |
| hERG | 0.225 |
| Ames | 0.017 |
| ROA | 0.026 |
| SkinSen | 0.931 |
| Carcinogencity | 0.146 |
| EI | 0.983 |
| Respiratory | 0.725 |
| NR-Aromatase | 0.005 |
| Antiviral | No |
| Prediction | 0.756214 |